title: Segregation of relaxed replicated dimers when DNA ligase and DNA polymerase I are limited during oriC-specific DNA replication.
abstract: An in vitro Escherichia coli oriC-specific DNA replication system was used to investigate the DNA replication pathways of oriC plasmids. When this system was perturbed by the DNA ligase inhibitor nicotinamide mononucleotide (NMN), alterations occurred in the initiation of DNA synthesis and processing of intermediates and DNA products. Addition of high concentrations of NMN soon after initiation resulted in the accumulation of open circular dimers (OC-OC). These dimers were decatenated to open circular monomers (form II or OC), which were then processed to closed circular supercoiled monomers (form I or CC) products. After a delay, limited ligation of the interlinked dimers (OC-OC to CC-OC and CC-CC) also occurred. Similar results were obtained with replication protein extracts from polA mutants. The presence of NMN before any initiation events took place prolonged the existence of nicked template DNA and promoted, without a lag period, limited incorporation into form II molecules. This DNA synthesis was nonspecific with respect to oriC, as judged by DnaA protein dependence, and presumably occurred at nicks in the template DNA. These results are consistent with oriC-specific initiation requiring closed supercoiled molecules dependent on DNA ligase activity. The results also show that decatenation of dimers occurs readily on nicked dimer and represents an efficient pathway for processing replication intermediates in vitro.
authors.affiliation: Experimental Biology Department, Roswell Park Memorial Institute, Buffalo, New York 14263.
authors.forename: B R
authors.initials: BR
authors.lastname: Munson
authors.forename: P G
authors.initials: PG
authors.lastname: Maier
authors.forename: R S
authors.initials: RS
authors.lastname: Greene
mesh_terms: D001426:Bacterial Proteins / Q000235:genetics* / Q000378:metabolism; D001483:Base Sequence / Q000187:drug effects; D011088:DNA Ligases / Q000037:antagonists & inhibitors*; D004256:DNA Polymerase I / Q000037:antagonists & inhibitors*; D004264:DNA Topoisomerases, Type I / Q000378:metabolism*; D004269:DNA, Bacterial / Q000096:biosynthesis* / Q000187:drug effects; D004587:Electrophoresis, Agar Gel; D004926:Escherichia coli / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism; D005798:Genes, Bacterial / Q000187:drug effects; D009536:Niacinamide / Q000494:pharmacology; D009690:Nucleic Acid Conformation / Q000187:drug effects; D010957:Plasmids / Q000187:drug effects; D011118:Polynucleotide Ligases / Q000037:antagonists & inhibitors*
chemical_list: D001426:Bacterial Proteins; D004269:DNA, Bacterial; D009536:Niacinamide; D004256:DNA Polymerase I; D004264:DNA Topoisomerases, Type I; D011088:DNA Ligases; D011118:Polynucleotide Ligases